Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05236387 · ClinicalTrials.gov registry record
Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 14
- Enrollment target
NCT05236387: Clinical Trial study, sponsored by Johns Hopkins University.
NCT05236387 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05236387 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of the present study is to evaluate the ability of 99mTc-TM to identify the clipped node after neoadjuvant chemotherapy (NAC) and to compare this percentage with historical national data. This study will also evaluate pain and discomfort after injection and pathological features of clipped nodes and any additional nodes removed.
Primary Outcome
The percentage of clipped nodes identified using 99mTc-TM will be calculated, along with an exact binomial 95% confidence interval.
Interventions
- DRUG 99m Tc-TM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2023-06-30 |
Why NCT05236387 stopped before completion
NCT05236387 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 99m Tc-TM is the first listed.
NCT05236387 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05236387 about?
NCT05236387 is a clinical study titled "Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection". The purpose of the present study is to evaluate the ability of 99mTc-TM to identify the clipped node after neoadjuvant chemotherapy (NAC) and to compare this percentage with historical national data. This study will also evaluate pain and discomfort after injection and pathological features of clipp...
What is the current status of trial NCT05236387?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2022-03-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05236387?
The interventions under investigation include: 99m Tc-TM (DRUG).
Who is sponsoring clinical trial NCT05236387?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy